Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
meeting tags : Therapy save search
Adicet Bio Highlights Preclinical Data Supporting IND Readiness for ADI-270 in an Oral Presentation at the American Society of Gene and Cell Therapy (ASGCT) 27th Annual Meeting
Published: 2024-04-22 (Crawled : 23:00) - biospace.com/
ACET | News | $2.0 2.56% 2.5% 260K
|
Health Technology
|
| O: 2.56%
H: 2.0%
C: 0.0%
adi-270 presentation cell preclinical for meeting therapy
Generation Bio Announces the Acceptance of Five Abstracts and an Invited Oral Presentation at the American Society of Gene and Cell Therapy (ASGCT) 27th Annual Meeting
Published: 2024-04-22 (Crawled : 21:00) - globenewswire.com
GBIO | News | $2.81 0.36% 0.18% 150K
|
Health Technology
| Email alert
Add to watchlist
presentation cell meeting therapy
TScan Therapeutics Announces Upcoming Presentations at the American Society of Gene and Cell Therapy 27th Annual Meeting
Published: 2024-04-22 (Crawled : 21:00) - globenewswire.com
TCRX | News 3 d | $7.12 4.4% 4.48% 170K
|
Professional, Scientific, and T...
| Email alert
Add to watchlist
cell meeting therapeutics therapy
CRISPR Therapeutics to Present Oral Presentation at the American Society of Gene & Cell Therapy (ASGCT) 2024 Annual Meeting
Published: 2024-04-22 (Crawled : 21:00) - globenewswire.com
CRSP | News M | $55.66 1.11% 1.17% 940K
|
Health Technology
| Email alert
Add to watchlist
crispr presentation cell meeting therapeutics therapy
Voyager Therapeutics to Present Broad Set of Translational Data Supporting IV-Delivered, CNS Gene Therapy Programs Advancing Toward Clinical Trials at the ASGCT 27th Annual Meeting
Published: 2024-04-22 (Crawled : 20:00) - globenewswire.com
SGMO | News | $0.5101 -0.27% 0.7% 1.3M
|
Health Technology
| Email alert
Add to watchlist
NBIX | News M | $133.66 1.26% 1.12% 460K
|
Health Technology
| Email alert
Add to watchlist
VYGR | News | $7.57 0.93% 0.92% 320K
|
Health Technology
| Email alert
Add to watchlist
trials meeting set therapeutics therapy
Editas Medicine to Present Pre-clinical Data Demonstrating Progression of in vivo Medicines Pipeline at the American Society of Gene and Cell Therapy Annual Meeting
Published: 2024-04-22 (Crawled : 20:00) - globenewswire.com
EDIT | News | $5.6 2.0% 2.31% 1.5M
|
Health Technology
| Email alert
Add to watchlist
pre-clinical pipeline cell meeting therapy
Theriva™ Biologics to Present Preclinical Data Supporting the Potential Synergy of VCN-01 and First-Line Pancreatic Cancer Chemotherapy Regimens at the American Society for Cell and Gene Therapy 27th Annual Meeting
Published: 2024-04-22 (Crawled : 20:00) - globenewswire.com
TOVX | News | $0.411 -1.01% 12.9% 230K
|
Manufacturing
| Email alert
Add to watchlist
vcn-01 cancer pancreatic cell preclinical for meeting potential therapy
Poseida Therapeutics Announces Strong Lineup of Presentations at the American Society of Gene and Cell Therapy 27th Annual Meeting
Published: 2024-04-18 (Crawled : 19:00) - biospace.com/
PSTX | $2.155 6.68% 6.48% 550K
|
Health Technology
|
| O: 0.25%
H: 0.0%
C: 0.0%
cell meeting therapeutics therapy
Immix Biopharma Announces Late-Breaking NXC-201 Clinical Data Abstract Accepted for Oral Presentation at the 27th Annual Meeting of the American Society of Gene and Cell Therapy (ASGCT)
Published: 2024-04-15 (Crawled : 14:00) - globenewswire.com
IMMX | $2.13 -2.74% 0.0% 190K
|
|
| O: 1.09%
H: 1.79%
C: -4.66%
nxc-201 presentation cell biopharma for meeting therapy
Caribou Biosciences Announces Oral Presentation on In Vivo Cas12a chRDNA Genome Editing at the 27th Annual Meeting of the American Society of Gene and Cell Therapy (ASGCT)
Published: 2024-04-15 (Crawled : 13:00) - globenewswire.com
CRBU | $3.99 3.64% 3.87% 1.4M
|
Health Technology
|
| O: -0.71%
H: 5.27%
C: -2.4%
presentation cell meeting therapy
Phio Pharmaceuticals Announces Upcoming Presentation at the 27th Annual Meeting of the American Society of Cell and Gene Therapy (ASCGT)
Published: 2024-04-11 (Crawled : 12:00) - phiopharma.com
PHIO | News | $0.8299 29.69% 22.63% 7M
|
Health Technology
|
| O: 3.8%
H: 1.15%
C: -1.19%
presentation cell pharmaceuticals meeting therapy
Genprex Collaborators Report Positive Preclinical Data on the Use of Reqorsa® and on NPRL2 Gene Therapy Utilizing Non-Viral Oncoprex® Delivery System for the Treatment of Lung Cancers at the 2024 AACR Annual Meeting
Published: 2024-04-09 (Crawled : 12:30) - prnewswire.com
GNPX | $2.163 1.55% 0.93% 19K
|
Health Technology
|
| O: 2.36%
H: 6.6%
C: 1.32%
reqorsa lung report positive treatment system preclinical for meeting therapy
GenFleet Therapeutics Announces Potent Anti-tumor Efficacy of GFH375, an Oral KRAS G12D (ON/OFF) Inhibitor, and its Potential in Combination Therapy with RAF/MEK Clamp at 2024 AACR Annual Meeting
Published: 2024-04-09 (Crawled : 11:00) - prnewswire.com
VSTM | $9.74 -1.02% -1.5% 95K
|
Health Technology
|
| O: 5.64%
H: 1.41%
C: -2.89%
gfh375 meeting therapeutics potential therapy
Century Therapeutics Presents New Preclinical Data Highlighting iPSC-derived Cell Therapy Platform Technology at the 2024 American Association for Cancer Research (AACR) Annual Meeting
Published: 2024-04-08 (Crawled : 20:00) - globenewswire.com
IPSC | $3.05 -1.29% -1.64% 66K
|
Professional, Scientific, and T...
|
| O: -1.59%
H: 8.87%
C: 7.8%
association cancer cell research preclinical for meeting technology therapeutics therapy platform
Theriva™ Biologics Announces Presentation at the American Society for Cell and Gene Therapy 27th Annual Meeting
Published: 2024-04-08 (Crawled : 12:00) - globenewswire.com
TOVX | News | $0.411 -1.01% 12.9% 230K
|
Manufacturing
|
| O: 0.62%
H: 2.02%
C: -1.11%
presentation cell for meeting therapy
Immunome to Present Preclinical Data for IM-3050, Its Lead Radioligand Therapy Candidate, at 2024 American Association for Cancer Research (AACR) Annual Meeting
Published: 2024-04-05 (Crawled : 14:30) - biospace.com/
IMNM | $15.28 -1.29% -1.11% 1.3M
|
Health Technology
|
| O: -0.44%
H: 3.37%
C: 0.45%
im-3050 association cancer research preclinical for meeting therapy
CRISPR Therapeutics to Present at the American Society of Gene & Cell Therapy (ASGCT) 2024 Annual Meeting
Published: 2024-04-01 (Crawled : 12:00) - globenewswire.com
CRSP | News M | $55.66 1.11% 1.17% 940K
|
Health Technology
|
| O: -2.41%
H: 0.23%
C: -0.03%
crispr cell meeting therapeutics therapy
Orchestra BioMed Demonstrates Strength of Cardiovascular Pipeline with Virtue® SAB and AVIM Therapy Presentations at CRT 2024 Annual Meeting
Published: 2024-03-13 (Crawled : 12:00) - globenewswire.com
MDT | $80.57 1.37% 0.0% 3.8M
|
Health Technology
|
| O: 0.31%
H: 0.4%
C: -1.08%
virtue pipeline meeting cardiovascular therapy
Genprex Collaborators to Present Positive Preclinical Data on the Use of Reqorsa® and on NPRL2 Gene Therapy Utilizing Non-Viral Oncoprex® Delivery System for the Treatment of Lung Cancers at the 2024 AACR Annual Meeting
Published: 2024-03-06 (Crawled : 13:30) - prnewswire.com
GNPX | $2.163 1.55% 0.93% 19K
|
Health Technology
|
| O: 24.27%
H: 5.66%
C: -14.45%
reqorsa lung positive treatment system preclinical meeting therapy
CareDx Showcases Digital Solutions and Pipeline in Cellular Transplant and Therapy Monitoring at the 2024 Tandem Meetings
Published: 2024-02-21 (Crawled : 23:00) - biospace.com/
CDNA | $8.17 -1.69% -1.71% 480K
|
Health Technology
|
| O: 0.24%
H: 0.85%
C: -0.12%
pipeline solutions therapy
Gainers vs Losers
| 73% | 27% |
Top 10 Gainers
MTTR | News M | $4.8 175.86% 63.6% 71M
|
AGBA | $2.5 100.0% 56.6% 200M
|
Finance
MLEC | $2.47 76.43% 42.62% 78M
|
n/a
NUWE | $0.334 29.96% 40.99% 2.5M
|
Manufacturing
EDBL | News | $6.26 66.49% 40.13% 16M
|
ATGL | $2.86 46.25% 32.8% 180K
|
ONFO | $0.6088 38.68% 27.74% 7.3M
|
n/a
VIVK | $1.43 33.65% 27.7% 530K
|
Professional, Scientific, and T...
MNTS | $0.5 35.69% 26.3% 4.7M
|
SDIG A | $3.64 35.32% 26.0% 990K
|
Your saved searches
Save your searches and get alerts when important news are released.